Outpatient Medical Abortion With Mifepristone and Misoprostol Through 77 Days of Gestation
Status:
Completed
Trial end date:
2016-04-01
Target enrollment:
Participant gender:
Summary
To demonstrate non-inferiority of the efficacy of 200 mg mifepristone followed in 24 to 48
hours by 800 µg buccal misoprostol in outpatient medical abortion services among women 71-77
days' compared to women 64-70 days' LMP.